Tokyo, Aug. 7 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062482) titled 'A study of deep vein thrombosis in total knee arthroplasty' on Aug. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Kamagaya General Hospital, Tokushukai Medical Corporation
Condition:
Condition - total knee arthroplasty
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - Clarifying the incidence and risk factors of deep vein thrombosis (DVT) in patients undergoing total knee arthroplasty may provide valuable information for prevention, treatment, and preoperative informed consent.
Basic objectives2 - Safety
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Patients who underwent total knee arthroplasty at our institution between July 2015 and June 2025
Key exclusion criteria - none
Target Size - 600
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2026 Year 05 Month 09 Day
Date of IRB - 2026 Year 06 Month 24 Day
Anticipated trial start date - 2026 Year 06 Month 26 Day
Last follow-up date - 2027 Year 06 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071503
Disclaimer: Curated by HT Syndication.
